Skip to main content

OPPENHEIMER ASSET MANAGEMENT INC.

Position in NVO — Novo Nordisk A S

CIK 1269119 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$41,917,582
+$11,177,678 QoQ
Shares Held
874,376
+4.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#60
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $503,921,348 across 14 Drug Manufacturers - General names. NVO ranks #5 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVO
Novo Nordisk A S
This page
874,376 $41,917,582

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,917,582 874,376
2026-03-31 $30,739,904 836,460
2025-12-31 $32,125,883 631,405
2025-09-30 $31,352,233 565,007
2025-06-30 $34,076,826 493,724
2025-03-31 $32,676,031 470,565
2024-12-31 $34,495,735 401,020
2024-09-30 $46,822,367 393,234
2024-06-30 $55,593,801 389,476
2024-03-31 $44,233,156 344,495
2023-12-31 $41,592,689 402,056
2023-09-30 $35,943,849 395,248
2023-06-30 $25,278,813 156,206
2023-03-31 $25,783,383 162,017
2022-12-31 $29,195,812 215,722
2022-09-30 $23,230,626 233,169
2022-06-30 $25,308,648 227,126
2022-03-31 $26,243,001 236,317
2021-12-31 $26,215,728 234,069
2021-09-30 $22,196,837 231,193
2021-06-30 $24,959,940 297,958
2021-03-31 $20,083,877 297,892
2020-12-31 $18,814,305 269,353
2020-09-30 $17,550,582 252,781
2020-06-30 $15,490,994 236,576
2020-03-31 $15,249,922 253,321